Citi Research opened Downside 30-Day Catalyst Watch on CR MEDICAL (01515.HK) +0.020 (+0.641%) Short selling $354.31K; Ratio 3.186% , expecting the company's 1H24 results to be a disappointment to the market mainly due to factors including the potential impairment of Huaiyin Hospital and slower-than-expected growth in revenue of China Resources Healthcare (Liaoning), according to a recent Citi Research report.
Expecting CR MEDICAL's share price to react negatively to the pressure on its results, the broker set the TP at $7 with a Buy rating.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2024-07-25 16:25.)
AAStocks Financial News
China's assets explosion and the high record global capital influx hit
Hong Kong Stocks Surge, Hang Seng Index Opens Up 543 Points
China's bailout policy triggers LVMH and Hermès to rise nearly 10%
Will policies boost confidence and the A-share market live up to expectations?
Check whenever you want
WikiStock APP